{"DataElement":{"publicId":"5935516","version":"1","preferredName":"Person Specimen Tumor Marker Central Pathology Review Clinical Trial Eligibility Criteria Status","preferredDefinition":"A response used to determine whether the condition or state of a substance that may be found in tumor tissue or released from a tumor into the blood or other body fluids that were sent to a central lab for confirmatory analysis met the characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol.","longName":"5935514v1.0:5935515v1.0","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"5935514","version":"1","preferredName":"Person Specimen Tumor Marker Central Pathology Review Clinical Trial Eligibility Criteria","preferredDefinition":"A human being._A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A substance that may be found in tumor tissue or released from a tumor into the blood or other body fluids. A high level of a tumor marker may mean that a certain type of cancer is in the body. Examples of tumor markers include CA 125 (in ovarian cancer), CA 15-3 (in breast cancer), CEA (in ovarian, lung, breast, pancreas, and gastrointestinal tract cancers), and PSA (in prostate cancer)._The process by which specimens are sent to a central lab for confirmatory analysis using standardized methods and result criteria in order to minimize inter-reviewer differences thereby improving the accuracy of pathology data._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"2236731v1.0:5935512v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"2236731","version":"1","preferredName":"Person","preferredDefinition":"A human being.","longName":"C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC6DF7-66EB-4CAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5935512","version":"1","preferredName":"Specimen Tumor Marker Central Pathology Review Clinical Trial Eligibility Criteria","preferredDefinition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:A substance that may be found in tumor tissue or released from a tumor into the blood or other body fluids. A high level of a tumor marker may mean that a certain type of cancer is in the body. Examples of tumor markers include CA 125 (in ovarian cancer), CA 15-3 (in breast cancer), CEA (in ovarian, lung, breast, pancreas, and gastrointestinal tract cancers), and PSA (in prostate cancer).:The process by which specimens are sent to a central lab for confirmatory analysis using standardized methods and result criteria in order to minimize inter-reviewer differences thereby improving the accuracy of pathology data.:Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"C19157:C17220:C71684:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Tumor Marker","conceptCode":"C17220","definition":"A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis of cancer, provide an estimation of tumor burden, and serve for monitoring effects of therapy, detecting recurrence, localization of tumors, and screening in general populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Central Pathology Review","conceptCode":"C71684","definition":"The process by which specimens are sent to a central lab for confirmatory analysis using standardized methods and result criteria in order to minimize inter-reviewer differences thereby improving the accuracy of pathology data.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"56DF7D8D-F686-0D9E-E053-F662850A24AF","latestVersionIndicator":"Yes","beginDate":"2017-08-16","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-16","modifiedBy":"ONEDATA","dateModified":"2017-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"56DF7D8D-F697-0D9E-E053-F662850A24AF","latestVersionIndicator":"Yes","beginDate":"2017-08-16","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-16","modifiedBy":"GARRIDOJ","dateModified":"2017-10-04","changeDescription":"Created for EA4151, 8/16/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5935515","version":"1","preferredName":"Tumor Marker Status","preferredDefinition":"A condition or state at a particular time.","longName":"5935515v1.0","context":"ECOG-ACRIN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"3 - Indeterminate","valueDescription":"Indeterminate","ValueMeaning":{"publicId":"2558962","version":"1","preferredName":"Indeterminate","longName":"2558962","preferredDefinition":"Cannot distinguish between two or more possible values in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B35F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"56DFA5D8-A666-0DA8-E053-F662850A6391","beginDate":"2017-08-16","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-16","modifiedBy":"ONEDATA","dateModified":"2017-08-16","deletedIndicator":"No"},{"value":"2 - Polyclonality","valueDescription":"Polyclonality","ValueMeaning":{"publicId":"5913681","version":"1","preferredName":"Polyclonality","longName":"5913681","preferredDefinition":"Having, or deriving from, two or more progenitors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Polyclonality","conceptCode":"C133817","definition":"Having, or deriving from, two or more progenitors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"549C0698-80A7-7BE3-E053-F662850A4228","latestVersionIndicator":"Yes","beginDate":"2017-07-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2017-07-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"56DFA5D8-A67C-0DA8-E053-F662850A6391","beginDate":"2017-08-16","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-16","modifiedBy":"ONEDATA","dateModified":"2017-08-16","deletedIndicator":"No"},{"value":"1 - Dominant sequences identified","valueDescription":"Dominant Sequence Identification","ValueMeaning":{"publicId":"5913680","version":"1","preferredName":"Dominant Sequence Identification","longName":"5913680","preferredDefinition":"Exercising influence or control.: A serial arrangement in which things follow in logical order or a recurrent pattern.: The procedure of having an identity established.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dominant","conceptCode":"C25487","definition":"Exercising influence or control.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Sequence","conceptCode":"C25673","definition":"A serial arrangement in which things follow in logical order or a recurrent pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Identification","conceptCode":"C25737","definition":"The procedure of having an identity established.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"549C0698-8082-7BE3-E053-F662850A4228","latestVersionIndicator":"Yes","beginDate":"2017-07-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2017-07-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"56DFA5D8-A692-0DA8-E053-F662850A6391","beginDate":"2017-08-16","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-16","modifiedBy":"ONEDATA","dateModified":"2017-08-16","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2404650","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"005AD6E5-057F-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"56DFA5D8-A643-0DA8-E053-F662850A6391","latestVersionIndicator":"Yes","beginDate":"2017-08-16","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-16","modifiedBy":"GARRIDOJ","dateModified":"2017-10-04","changeDescription":"Created for EA4151, 8/16/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3314482","version":"1","longName":"Type of Category","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"10000277","version":"1","longName":"Eligibility","context":"ECOG-ACRIN"},{"publicId":"3314494","version":"1","longName":"Labs","context":"ECOG-ACRIN"},{"publicId":"10000047","version":"1","longName":"Pathology","context":"ECOG-ACRIN"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Indicate the level/status tha","type":"Preferred Question Text","description":"Indicate the level/status that was determined centrally and reported to you.","url":null,"context":"ECOG-ACRIN"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"56DFC85E-94B9-7AA3-E053-F662850A5547","latestVersionIndicator":"Yes","beginDate":"2017-08-16","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-16","modifiedBy":"GARRIDOJ","dateModified":"2017-10-04","changeDescription":"Created for EA4151, 8/16/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}